Literature DB >> 1698361

Characterization of the human immunodeficiency virus type-1 reverse transcriptase enzyme produced in yeast.

I C Bathurst1, L K Moen, M A Lujan, H L Gibson, P H Feucht, S Pichuantes, C S Craik, D V Santi, P J Barr.   

Abstract

The reverse transcriptase (RT) of human immunodeficiency virus type-1 (HIV-1) is comprised of two subunits of approximately 66kD and 51kD. We have defined the carboxyl terminus of the 51kD molecule using the 66kD RT and HIV-1 protease (PR) expressed in yeast. Precise constructs encoding the 66kD and 51kD molecules were expressed individually, in yeast, at high levels. The purified recombinant subunits were shown to associate into heterodimers that retained both RT and RNase H activities. Only the 66kD molecule could associate into homodimers. Such homodimers retained approximately 80% of the RT activity of the heterodimers. Our data demonstrates that the 51/66kD heterodimer, analogous to that found in vivo, can be reconstituted in vitro and is more efficient in both RT and RNase H activity than the homodimer.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1698361     DOI: 10.1016/0006-291x(90)91187-w

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  5 in total

1.  Virion instability of human immunodeficiency virus type 1 reverse transcriptase (RT) mutated in the protease cleavage site between RT p51 and the RT RNase H domain.

Authors:  Michael E Abram; Michael A Parniak
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

2.  Chemical crosslinking of the subunits of HIV-1 reverse transcriptase.

Authors:  Z Debyser; E De Clercq
Journal:  Protein Sci       Date:  1996-02       Impact factor: 6.725

3.  The mutation T477A in HIV-1 reverse transcriptase (RT) restores normal proteolytic processing of RT in virus with Gag-Pol mutated in the p51-RNH cleavage site.

Authors:  Michael E Abram; Stefan G Sarafianos; Michael A Parniak
Journal:  Retrovirology       Date:  2010-02-01       Impact factor: 4.602

4.  In vitro effect of antisense oligonucleotides on human immunodeficiency virus type 1 reverse transcription.

Authors:  B Bordier; C Hélène; P J Barr; S Litvak; L Sarih-Cottin
Journal:  Nucleic Acids Res       Date:  1992-11-25       Impact factor: 16.971

5.  New tetrahydroimidazo[4,5,1-jk][1,4]-benzodiazepin-2(1H)-one and -thione derivatives are potent inhibitors of human immunodeficiency virus type 1 replication and are synergistic with 2',3'-dideoxynucleoside analogs.

Authors:  R Pauwels; K Andries; Z Debyser; M J Kukla; D Schols; H J Breslin; R Woestenborghs; J Desmyter; M A Janssen; E De Clercq
Journal:  Antimicrob Agents Chemother       Date:  1994-12       Impact factor: 5.191

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.